Literature DB >> 21218179

Cutaneous Connective Tissue Diseases: Epidemiology, Diagnosis, and Treatment.

Bobby Y Reddy1, Basil M Hantash.   

Abstract

Connective tissue diseases (CTDs) are a group of clinical disorders that have an underlying autoimmune pathogenesis. These include a diverse set of diseases such as relapsing polychondritis, rheumatoid arthritis, and eosinophilic fasciitis, along with more common entities like Sjogren's syndrome, dermatomyositis, scleroderma, and lupus erythematosus. The latter three will be the focus of this review, as they constitute the most significant and common CTD with cutaneous manifestations. The cutaneous signs often represent the preliminary stages of disease and the presenting clinical symptoms. Therefore, comprehensive knowledge of CTD manifestations is essential for accurate diagnosis, better assessment of prognosis, and effective management. Although the precise etiologies of CTDs remain obscure, recent advances have allowed for further understanding of their pathogenesis and improved disease classifications. In addition, there have been developments in therapeutic options for CTDs. This review provides an overview of the epidemiology, clinical presentations, and current treatment options of cutaneous lupus erythematous, dermatomyositis and scleroderma.

Entities:  

Year:  2009        PMID: 21218179      PMCID: PMC3016048          DOI: 10.2174/1874372200903010022

Source DB:  PubMed          Journal:  Open Dermatol J


  58 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Endothelin and endothelin receptor antagonists in systemic rheumatic disease.

Authors:  Maureen D Mayes
Journal:  Arthritis Rheum       Date:  2003-05

3.  Evidence for a role of type I interferons in the pathogenesis of dermatomyositis.

Authors:  J Wenzel; M Scheler; T Bieber; T Tüting
Journal:  Br J Dermatol       Date:  2005-08       Impact factor: 9.302

4.  International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement.

Authors:  C Vitali; A Doria; A Tincani; P Fabbri; G Balestrieri; M Galeazzi; P L Meroni; P Migliorini; R Neri; A Tavoni; S Bombardieri
Journal:  Clin Exp Rheumatol       Date:  1996 Nov-Dec       Impact factor: 4.473

Review 5.  Cutaneous lupus erythematosus.

Authors:  D P McCauliffe
Journal:  Semin Cutan Med Surg       Date:  2001-03

6.  Distinctive cutaneous subsets in the spectrum of lupus erythematosus.

Authors:  J N Gilliam; R D Sontheimer
Journal:  J Am Acad Dermatol       Date:  1981-04       Impact factor: 11.527

Review 7.  Localized scleroderma is an autoimmune disorder.

Authors:  K Takehara; S Sato
Journal:  Rheumatology (Oxford)       Date:  2004-11-23       Impact factor: 7.580

8.  Dermatomyositis: a dermatology-based case series.

Authors:  M A Dawkins; J L Jorizzo; F O Walker; D Albertson; S H Sinal; A Hinds
Journal:  J Am Acad Dermatol       Date:  1998-03       Impact factor: 11.527

Review 9.  Cutaneous lupus erythematosus: a review.

Authors:  Purvisha Patel; Victoria Werth
Journal:  Dermatol Clin       Date:  2002-07       Impact factor: 3.478

10.  Incidence of systemic lupus erythematosus. Race and gender differences.

Authors:  D J McCarty; S Manzi; T A Medsger; R Ramsey-Goldman; R E LaPorte; C K Kwoh
Journal:  Arthritis Rheum       Date:  1995-09
View more
  1 in total

1.  A Case of Extensive Debilitating Generalized Morphea.

Authors:  Amit Sapra; Rebecca Dix; Priyanka Bhandari; Asiya Mohammed; Eukesh Ranjit
Journal:  Cureus       Date:  2020-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.